Stockscreener 앱 받기
86.06
1.56%
1.37
시간 외 거래:
86.06
전일 마감가:
$84.69
열려 있는:
$83.01
하루 거래량:
379.11K
Relative Volume:
0.90
시가총액:
$2.99B
수익:
-
순이익/손실:
$-91.00M
주가수익비율:
-23.45
EPS:
-3.67
순현금흐름:
$-74.38M
1주 성능:
-1.83%
1개월 성능:
+26.90%
6개월 성능:
+73.72%
1년 성능:
+47.66%
1일 변동 폭
$83.01
$87.12
1주일 범위
$83.01
$87.51
52주 변동 폭
$30.82
$95.95
Disc Medicine Inc Stock (IRON) Company Profile
명칭
Disc Medicine Inc
전화
(617) 674-9274
주소
321 ARSENAL STREET, SUITE 101, WATERTOWN
IRON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
86.06 | 3.17B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.80 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.77 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.25 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.84 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.74 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-06-11 | 재개 | Raymond James | Strong Buy |
| 2025-02-27 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | 개시 | Jefferies | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-08-22 | 개시 | Wells Fargo | Overweight |
| 2024-04-01 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | 개시 | H.C. Wainwright | Buy |
| 2023-05-17 | 개시 | Raymond James | Outperform |
| 2023-04-28 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-21 | 개시 | Stifel | Buy |
| 2023-04-20 | 개시 | Morgan Stanley | Overweight |
| 2023-03-23 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-28 | 개시 | SVB Securities | Outperform |
모두보기
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Disc Medicine to present initial DISC-0974 data from RALLY-MF trial - Investing.com Australia
Disc Medicine (NASDAQ:IRON) Earns Buy Rating from Analysts at Stifel Nicolaus - MarketBeat
Will Disc Medicine Inc. stock recover faster than marketMarket Performance Recap & Fast Gaining Stock Strategy Reports - newser.com
Is Disc Medicine Inc. stock trading near support levelsInsider Buying & Long Hold Capital Preservation Plans - newser.com
Is Disc Medicine Inc. stock attractive for passive investors2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Stifel Reiterates Disc Medicine (IRON) Buy Recommendation - Nasdaq
Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting - The Manila Times
Disc Medicine (NASDAQ: IRON) to present RALLY-MF Phase 2 data at ASH with JAK combos - Stock Titan
What makes Disc Medicine Inc. stock attractive to growth fundsJuly 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
IRON: Stifel Reinstates 'Buy' Rating with New Price Target of $1 - GuruFocus
Disc Medicine (IRON) Receives Buy Rating with Promising Outlook - GuruFocus
How to escape a deep drawdown in Disc Medicine Inc.2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com
How sustainable is Disc Medicine Inc. stock dividend payoutQuarterly Portfolio Summary & AI Powered Market Entry Ideas - newser.com
Applying Wyckoff theory to Disc Medicine Inc. stockJuly 2025 Fed Impact & Advanced Technical Analysis Signals - newser.com
Is Disc Medicine Inc. stock in correction or buying zoneGold Moves & Low Drawdown Trading Strategies - newser.com
Can Disc Medicine Inc. stock weather global recession2025 Key Lessons & Growth Focused Entry Reports - newser.com
Will Disc Medicine Inc. stock maintain growth storyJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - newser.com
How Disc Medicine Inc. stock performs in interest rate cyclesJuly 2025 Movers & Safe Entry Point Identification - newser.com
Why Disc Medicine Inc. stock is considered a top pickExit Point & Entry Point Confirmation Signals - newser.com
Morgan Stanley Issues Positive Forecast for Disc Medicine (NASDAQ:IRON) Stock Price - MarketBeat
Disc Medicine stock reiterated Strong Buy at Raymond James on DISC-0974 potential - Investing.com
Analysts Conflicted on These Healthcare Names: Kyverna Therapeutics, Inc. (KYTX), Disc Medicine (IRON) and Baxter International (BAX) - The Globe and Mail
Disc Medicine to Participate in Upcoming Investor Conferences - Enidnews.com
Disc Medicine (NASDAQ: IRON) to appear at Guggenheim, Stifel, Jefferies; live webcasts - Stock Titan
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
What valuation multiples suggest for Disc Medicine Inc. stockEarnings Growth Summary & Real-Time Chart Breakout Alerts - newser.com
WilmerHale Advises Underwriters in $287.5 Million Public Offering of Disc Medicine - WilmerHale
IRON Stock: Morgan Stanley Raises Price Target to $115 | IRON St - GuruFocus
Morgan Stanley Raises Price Target on Disc Medicine to $115 From $90, Keeps Overweight Rating - MarketScreener
Disc Medicine’s Promising Anemia Treatment Study: Key Insights for Investors - MSN
Chronic Kidney Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Jiangsu HengRui, Disc Medicine, 3SBio, Kind Pharma, Jiangsu Hansoh Pharm - Barchart.com
Disc Medicine (IRON): Evaluating Valuation After New Clinical Trial Plans and FDA Recognition Boost Pipeline Momentum - Yahoo Finance
Disc Medicine, Inc. (IRON) stock forecast and price target - Yahoo! Finance UK
Disc Medicine planning trial of iron overload treatment for sickle cell - Sickle Cell Disease News
Aug Chart Watch: Why Disc Medicine Inc. stock is considered a top pickQuarterly Earnings Summary & Daily Entry Point Trade Alerts - fcp.pa.gov.br
Why Disc Medicine Inc. stock remains a top recommendationWeekly Trading Summary & Accurate Intraday Trade Tips - fcp.pa.gov.br
Disc Medicine Inc (IRON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):